Cyclopharm Share Price and Company Fundamentals



Price
$2.55
Change
-0.070 (-2.672%)
52 week
1.205 - 3.45

Last traded: Today at 5:55 AM

Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

Key Metrics

PE ratio

-

PB ratio

11.97

Dividend yield

0.38%

Beta

0.62

Market cap

$238.11M

Enterprise value

$240.94M

Company profile

Primary activitiesThe Company produces and supplies the medical profession with proprietary lung radiopharmaceuticals.
Industry / SectorMedical Devices / Healthcare
Full time employees48
Websitehttp://www.cyclopharm.com.au
Mailing address1 The Crescent Unit 4 Kingsgrove NSW 2208 Australia
Phone / Fax61 2 9541 0411 / 61 2 9543 0960
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Cyclopharm Dividend history, yield and payout ratio

Dividend yield

0.38%

Dividend amount

$0.01

Payout ratio

5Y Avg. yield

0.88%

Cyclopharm paid $0.01 dividend and the ex-dividend date was 01 Apr 2021.The dividend payout ratio is . The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.

CYC's forward dividend amount is $0.01 and the forward dividend yield is 0.39%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of May 2021, following are the company executives and directors listed on Cyclopharm.

NameTitleAgeTotal Pay
Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIMCEO, MD, Company Sec. & Director55535.93k
Mr. Mathew FaragChief Operating Officer325.28k
Mr. Graham N. PhillipsFin. Mang.
Dr. Mark DovertyGlobal Head of Regulatory Compliance & Clinical Research
Ms. Sally-Ann CorneliusHead of Sales
Ms. Niamh McAreeHead of Quality and Regulatory
Mr. Chris QuinnHead of Service
Ms. Sui Ling CheahFinancial Controller50
Mr. Lynn McLauchlinGen. Mang. of Canada
Mr. Gary T. SomervilleQuality & Regulatory Mang.

Profitability and management effectiveness

Profit margin

-34.18%

Operating margin

-28.23%

Return on assets

-10.26%

Return on equity

-29.98%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cyclopharm is 238.11M and its enterprise value is 240.94M. The enterprise value to revenue ratio of CYC is 13.63.

The CYC's stocks Beta value is 0.62 making it 38% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Cyclopharm (CYC)

Cyclopharm (ASX:CYC) Frequently Asked Questions

1. What is Cyclopharm's Stock Symbol?

Cyclopharm trades on ASX under the ticker symbol "CYC".

2. What is Cyclopharm's stock price today?

One share of CYC stock can currently be purchased for approximately $2.55.

3. How can I contact Cyclopharm?

Cyclopharm's mailing address is 1 The Crescent Unit 4 Kingsgrove NSW 2208 Australia. The company can be reached via phone at 61 2 9541 0411.

4. What is Cyclopharm's official website?

The official website of Cyclopharm is http://www.cyclopharm.com.au.

5. Which share registry manages Cyclopharm's stock?

Cyclopharm's stock is managed by AUTOMIC REGISTRY SERVICES.